References
- FMOH. Integrated national guidelines for HIV prevention treatment and care; 2016. Available from: http://www.health.gov.ng/. Accessed June 28, 2023.
- Brinkman K, Kakuda T. Mitochondrial toxicity of nucleoside analogue reverse transcriptase inhibitors: a looming obstacle for long-term antiretroviral therapy? Curr Opin Infect Dis. 2000;13:5–11. doi:10.1097/00001432-200002000-00002
- Lewis W, Dalakas M. Mitochondrial toxicity of antiviral drugs. Nat Med. 1995;1:417–422. doi:10.1038/nm0595-417
- López S, Coll O, Durban M, et al. Mitochondrial DNA depletion in oocytes of HIV-infected antiretroviral-treated infertile women. Antivir Ther. 2008;13(6):833–838. doi:10.1177/135965350801300607
- Saksena NK, Wang B, Zhou L, Soedjono M, Ho YS, Conceicao V. HIV reservoirs in vivo and new strategies for possible eradication of HIV from the reservoir sites. HIV/AIDS Res Palliat Care. 2010;103–122. doi:10.2147/HIV.S6882
- Poss M, Martin HL, Kreiss JK, et al. Diversity in virus populations from genital secretions and peripheral blood from women recently infected with human immunodeficiency virus type 1. J Virol. 1995;69(12):8118–8122. doi:10.1128/jvi.69.12.8118-8122.1995
- Lewis W, Copeland W, Mitochondrial DB. DNA depletion, oxidative stress, and mutation: mechanisms of nucleoside reverse transcriptase inhibitor toxicity. Lab Invest. 2001;81:777–790. doi:10.1038/labinvest.3780288
- American College of Obstetrics and Gynecology. Ovarian reserve testing- committee opinion; 2015. Available from: https://www.acog.org. Accessed March 21, 2017.
- Seifer D, Golub E, Lambert-Messerlian G, et al. Biologic markers of ovarian reserve and reproductive aging: application in a cohort study of HIV infection in women. Fertil Steril. 2007;88:1645–1652. doi:10.1016/j.fertnstert.2007.01.122
- Clark R, Mulligan K, Stamenovic E, et al. Frequency of anovulation and early menopause among women enrolled in selected adult AIDS clinical trials group studies. J Infect Dis. 2001;184:1325–1327.
- Santulli P, De Villardi D, Gayet V, et al. Decreased ovarian reserve in HIV infected women. AIDS. 2016;30:1083–1088. doi:10.1097/QAD.0000000000001025
- Bancroft J, Stevens A. Theory and Practice of Histological Techniques. Edinburgh: Churchill Livingstone; 1982.
- White B, Porterfield S. Endocrine and Reproductive Physiology. 4th ed. Philadelphia, PA: Elsevier/Mosby; 2012.
- Andrews WW, Ojeda SRA. Detailed analysis of the serum LH secretory profiles of conscious free-moving female rats during the time of puberty. Endocrinology. 1981;109(6):20323–20329.
- Awodele O, Popoola TD, Idowu O, Bashua BM, Awolola NA. Investigations into the risk of reproductive toxicity following exposure to highly active anti-retroviral drugs in Rodents Tokai. J Exp Clin Med. 2018;43(2):54–63.
- Collazos J, Martinez E, Mayo J, Ibarra S. Sexual hormones in HIV infected patients: the influence of antiretroviral therapy. AIDS. 2002;16(6):934–937. PMID: 11919500. doi:10.1097/00002030-200204120-00018
- Hemati A, Azarnia M, Nabiuni M, et al. Effect of the hydroalcoholic extract of Heracleum persicum (Golpar) on Folliculogenesis in female Wistar rats. Cell J Spring. 2012;14:47–52.
- Kevenaar EM, Meerasahib FM, Kramer P, et al. Serum anti-mullerian hormone levels reflect the size of the follicle pool in mice. Endocrinology. 2006;14:3228–3234. doi:10.1210/en.2005-1588
- Nathalie J, Nathalie D. Anti- mullerian hormone. Encyclopedia of Endocrine Disease; 2017. Available from: http://www.sciencedirect.com/topics/neuroscience/anti-mullerian-hormone. Accessed November 22, 2017.
- Motohiro K, Amanda ES, Zhang LH, et al. AMH as a contraceptive that protects the ovarian reserve during chemotherapy; 2016. Available from: http://www.pnas.org/content/114/9/E1688.full.pdf. Accessed November 22, 2017.
- Lamda H, Goldmeier D, Mackie NE, Scullard G. Anti-retroviral therapy is associated with sexual dysfunction and with increased oestradiol levels in men. Int J STD Aids. 2004;15:234–237. doi:10.1258/095646204773557749
- Fan MD, Maslow B-S, Santoro N, Schoenbaum E. HIV and the menopause. Menopause Int. 2007;14:163–168. doi:10.1258/mi.2008.008027
- Kahwati LC, Haigler L, Rideout S. What is the best way to diagnose menopause? J Fam Pract. 2005;54:1000–1002.
- Taylor-Robinson SD. Do medical algorithms always benefit the patient? - A patient perspective. QJM. 2023;116:474–475. doi:10.1093/qjmed/hcac254